236 related articles for article (PubMed ID: 25107939)
1. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.
Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A
Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939
[TBL] [Abstract][Full Text] [Related]
2. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
Rose T; Grützkau A; Hirseland H; Huscher D; Dähnrich C; Dzionek A; Ozimkowski T; Schlumberger W; Enghard P; Radbruch A; Riemekasten G; Burmester GR; Hiepe F; Biesen R
Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
[TBL] [Abstract][Full Text] [Related]
3. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic associations of anti-ribosomal P protein antibody titres and their subclasses in patients with systemic lupus erythematosus.
Kaneko Y; Sato H; Wakamatsu A; Kobayashi D; Sato K; Kurosawa Y; Hasegawa E; Nakatsue T; Kuroda T; Narita I
Rheumatology (Oxford); 2024 May; 63(5):1411-1421. PubMed ID: 37572300
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
[TBL] [Abstract][Full Text] [Related]
6. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
7. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of multiplex immune assay of antinuclear antibodies in systemic lupus erythematosus.].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Panafidina TA; Popkova TV; Lukina GV
Klin Lab Diagn; 2018; 63(7):434-438. PubMed ID: 30720960
[TBL] [Abstract][Full Text] [Related]
10. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
11. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?
Capper ER; Maskill JK; Gordon C; Blakemore AI
Clin Exp Immunol; 2004 Nov; 138(2):348-56. PubMed ID: 15498048
[TBL] [Abstract][Full Text] [Related]
12. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
15. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
16. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
17. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.
Hermansen ML; Hummelshøj L; Lundsgaard D; Hornum L; Keller P; Fleckner J; Fox B; Poulsen LK; Jacobsen S
Lupus; 2012 Sep; 21(10):1098-104. PubMed ID: 22577117
[TBL] [Abstract][Full Text] [Related]
18. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
[TBL] [Abstract][Full Text] [Related]
20. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
